Daniel Savic
Impact in
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- Single-cell and spatial transcriptomics
- Genetics top 5%
- Genetic Associations and Epidemiology
- Estrogen and related hormone effects
Papers in
-
- Acute Lymphoblastic Leukemia research 13
-
- Genomics and Chromatin Dynamics 12
- Epigenetics and DNA Methylation 1
- Protein Degradation and Inhibitors 1
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- Richard M. Myers (7 shared papers)Marcelo A. Nóbrega (5 shared papers)Noboru J. Sakabe (1 shared paper)Jason Gertz (3 shared papers)Gregory M. Cooper (2 shared papers)E. Christopher Partridge (2 shared papers)Timothy E. Reddy (1 shared paper)Katherine Elena Varley (1 shared paper)
- Journals
- Nature Communications (3 papers)Nature (3 papers)PLoS ONE (2 papers)JNCI Journal of the National Cancer Institute (2 papers)Leukemia (2 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Daniel Savic
29 papers receiving 2.8k citations
Daniel Savic's Hit Papers
Peers
Comparison fields: 5 of 99
- Molecular Biology 1.6k
- Genetics 529
- Cancer Research 224
- Immunology 162
- Biological Psychiatry 9
Countries citing papers authored by Daniel Savic
This map shows the geographic impact of Daniel Savic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Savic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Savic more than expected).
Fields of papers citing papers by Daniel Savic
This network shows the impact of papers produced by Daniel Savic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Savic. The network helps show where Daniel Savic may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Savic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expanded encyclopaedias of DNA elements in the human and mouse genomes Hit paper breakdown → | 2020 | 1438 |
| 2 | 2013 | 261 | |
| 3 | 2020 | 146 | |
| 4 | 2015 | 137 | |
| 5 | 2012 | 111 | |
| 6 | 2020 | 94 | |
| 7 | 2017 | 89 | |
| 8 | 2019 | 80 | |
| 9 | 2016 | 69 | |
| 10 | 2020 | 57 | |
| 11 | 2020 | 40 | |
| 12 | 2016 | 36 | |
| 13 | 2014 | 26 | |
| 14 | 2013 | 23 | |
| 15 | 2011 | 18 | |
| 16 | 2012 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2022 | 16 | |
| 20 | 2022 | 14 |
About Daniel Savic
Daniel Savic is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Genetics, Pharmacology and Cancer Research, having authored 31 papers that have together received 2.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (13 papers), Genomics and Chromatin Dynamics (12 papers), Genetic Associations and Epidemiology (3 papers), Pancreatic function and diabetes (2 papers), Epigenetics and DNA Methylation (1 paper), Schizophrenia research and treatment (1 paper), Protein Degradation and Inhibitors (1 paper) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Molecular Biology (1.6k citations), Genetics (529 citations), Cancer Research (224 citations), Immunology (162 citations) and Biological Psychiatry (9 citations). Daniel Savic has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Richard M. Myers, Marcelo A. Nóbrega, Noboru J. Sakabe, Jason Gertz, Gregory M. Cooper, E. Christopher Partridge, Timothy E. Reddy, Katherine Elena Varley, Alexias Safi and Gregory E. Crawford. Their work appears in journals such as Nature Communications, Nature, PLoS ONE, JNCI Journal of the National Cancer Institute and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.